Study: Can the restriction of fermentable carbohydrates help children with irritable bowel syndrome?

Referenz Chumpitazi BP, Cope JL, Hollister EB, et al. Randomisierte klinische Studie: Darmmikrobiom-Biomarker sind mit dem klinischen Ansprechen auf eine FODMAP-arme Ernährung bei Kindern mit Reizdarmsyndrom assoziiert. Nahrungsmittel Pharmacol. Ther. 2015;42(4):418-427. Design Randomisierte, doppelblinde Crossover-Studie Teilnehmer Dreiunddreißig Kinder (Alter 7-17 Jahre) mit Reizdarmsyndrom (IBS) gemäß ROME III-Fragebogen zum Magen-Darm-Trakt (GI). Studienparameter bewertet Alle Teilnehmer aßen 7 Tage lang ihre gewohnte Ernährung, um die Grundlinie festzulegen. Es wurden Stuhlproben zur Bestimmung von Mikrobiom-Taxa gewonnen. Diät 1 oder Diät 2 wurde dann 48 Stunden lang eingenommen; Es folgte eine 5-tägige Auswaschphase, während der die gewohnte Ernährung konsumiert wurde, dann wurden die Teilnehmer …
Reference Chumpitizizi BP, Cope JL, Hollister EB, et al. Randomized clinical study: Darmicrobiom biomarkers are associated with the clinical response to a fodmap-poor diet in children with irritable bowel syndrome. Food pharmacol. Ther. 2015; 42 (4): 418-427. Design randomized, double-blind crossover study participant in three and thirty children (age 7-17 years) with irritable bowel syndrome (IBS) according to Rome III questionnaire to the gastrointestinal tract (GI). Study parameters evaluate all participants at 7 days ate their usual diet to set the baseline. Stool samples were obtained to determine microbiome taxa. Diet 1 or diet 2 was then taken for 48 hours; A 5-day washing phase followed, during which the usual diet was consumed, then the participants became ... (Symbolbild/natur.wiki)

Study: Can the restriction of fermentable carbohydrates help children with irritable bowel syndrome?

Reference

chrumptitizi BP, Cope JL, Hollister EB, et al. Randomized clinical study: Darmicrobiom biomarkers are associated with the clinical response to a fodmap-poor diet in children with irritable bowel syndrome. food pharmacol. Ther. 2015; 42 (4): 418-427.

Design

randomized, double-blind crossover study

participant

Thirty-three children (age 7-17 years) with irritable bowel syndrome (IBS) according to Rome III questionnaire to the gastrointestinal tract (GI).

study parameters evaluated

All participants ate their usual diet for 7 days to set the baseline. Stool samples were obtained to determine microbiome taxa. Diet 1 or diet 2 was then taken for 48 hours; A 5-day washing phase followed, during which the usual diet was consumed, the participants were switched to the other diet. Diet 1 consisted of a diet with little fermentable oligosaccharides, disaccecharides, monosaccharides and polyols (fodmaps), which contained 9 g of fod maps per day. Diet 2 consisted of a typical American childhood diet (TACD), which contained a maximum of 50 g of fod maps per day.

primary result measurements

The frequency of abdominal pain was the primary endpoint, which was rated through a pain and chair diary over 24-hour periods during the Baseline and during the 2 days of every nutritional intervention.
Secondary endpoints were associated symptoms such as flatulence, flatulence, nausea and heartburn.
The basic microbiological composition of the intestine (uncovered by 16S-RRNA sequencing) and the metabolic capacity of the organisms were determined. The comparison of the starting microbioma was divided into a responder group (≥50 % decrease in the frequency of abdominal pain only at low fodmap diet) and a non-responder group (no improvement during both interventions).

important knowledge

When comparing the diets, less abdominal pain occurred during the low-Fodmap diet than with the TACD (1.1 ± 0.2 standard error of the average). [Sem] Episoden/D vs. 1.7 ± 0.4 Sem-episodes/d, p <0.05). There were also fewer episodes of abdominal pain in the Fodmap diet ( p <0.01) and more episodes on the TACD ( p <0.01) compared to the initial value. The microbiomas of the responders were more enriched with taxa with greater fermentation ability (e.g. bacteroid , ruminococcaceae , faecalibacterium prausnitzii ).

practice implications

The concept of irritable bowel syndrome in children recently was used by Sandhu et al. 1 A low-fodmap diet was used to treat adults with irritable bowel syndrome. 2-4 So far, every application of low-fodmap diet in children on adult populations. This study by Chumpitizi and colleagues confirms that there could be a therapeutic role in a low-Fodmap diet in pediatric IBS. It also illuminates the role of microbiota when using a low-Fodmap diet in IBS in childhood.
The authors of this study had previously shown a benefit for children according to the Fodmap diet in a small open study. 5 they observed that children whose symptoms best respond to a low-fodmap diet showed another microbiota composition than those whose symptoms did not speak. These preliminary results led to the current randomized, double-blind crossover study that is checked here.
Ultimately, we have to consider that the restriction of fermentative carbohydrates can create long -term risks through changes in the intestinal environment over longer periods (months or years).
The current study confirms the assumption of the authors that the benefits of a FodMap-poor nutrition are related to a certain bacterial composition. The responders had microbes from several taxa, including bacteroids , ruminococcaceae , faecalibactterium prausnitzii and dorea , all of which have a greater fermentative potential. The Nonresponder had a larger number of genus turicibacter , which are known to have a lower fermentation ability. This indicates that NonResponder have a bacterial composition that is less fermented; Therefore, removing fermentable carbohydrates has very low effects on their IBS symptoms.
This study presents the concept of a more individual approach for the use of the low-Fodmap diet. Ideally, doctors can assess the microbiome one day before starting with the Fodmap diet and perhaps save some children (or adults) the stress of such a limited diet.
While the FodMap diet can control the symptoms in patients with IBS, 6 The diet should be used with some caution. The application of the low-Fodmap diet (and/or the specific carbohydrate diet) over longer periods has not proven to be safe in long-term studies. The concern is that many of the restricted FODMAP foods (e.g. legumes, garlic, some wholemeal products) are of crucial importance for the health of the intestine. 7 fermentable carbohydrates increase the variety of bacteria in the large intestine and promote growth firmicutes , bacteroid and bifidobacterium . These types of bacteria produce short-chain fatty acids-propionate, butyrating and acetate-all of which are necessary for a healthy gastrointestinal tract. A recently carried out study has shown that a changed microbiota appears after patients have only taken a low-Fodmap diet for 21 days.
As a clinician, we initially do not have to harm our patient. As this study has shown, the use of a FodMap-poor diet can alleviate IBS symptoms, for some in just 48 hours. If this study had kept the children on a low-Fodmap diet for 7 days, as is common in adults, we might have seen a larger reaction to the diet.
Ultimately, we have to consider that by restricting fermentative carbohydrates over longer periods (months or years), we can also create long-term risks through changes in the intestinal environment, including increased inflammation and even colon cancer. 9-12 As always, it is to help the patient back to optimal health, so that a varied diet is resumed can.

  1. Sandhu BK, Paul sp. Significant syndrome in children: pathogenesis, diagnosis and evidence -based treatment. world J Gastroenterol. 2014; 20 (20): 6013-6023.
  2. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir Jg. A diet with little fodmaps reduces the symptoms of irritable bowel syndrome. gastroenterology. 2014; 146 (1): 67-75.
  3. Ong DK, Mitchell SB, Barrett JS, et al. The manipulation of short -chain carbohydrates in food changes the pattern of gas production and the development of symptoms in irritable bowel syndrome. j Gastroenterol Hepatol. 2010; 25 (8): 1366-1373.
  4. Shepherd SJ, Gibson Pr. Fructosemal absorption and symptoms of irritable bowel syndrome: guidelines for effective nutrition management. j am Diet Assoc. 2006; 106 (10): 1631-1639.
  5. chumpitazizi BP, Hollister EB, Oezguen n, et al. The intestinal microbiota influences the effectiveness of a diet with low fermentable substrates in children with irritable bowel syndrome. intestinal microbes. 2014; 5 (2): 165-175.
  6. Staudacher HM, Lomer MC, Anderson JL, et al. The restriction of fermentable carbohydrates reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012; 142 (8): 1510-1518.
  7. Simpson HL, Campbell Bj. Overview article: Interactions between fiber and microbiota. food pharmacol. Ther. 2015; 42 (2): 158-179.
  8. Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir Jg. Diets that differ in their fodmap content change the luminal micro environment of the large intestine. Darm. 2015; 64 (1): 93-100.
  9. Tamboli CP, Neut C, Desreumaux P, Colombel jf. Dysbiosis as a prerequisite for CED. intestine. 2004; 53 (7): 1057.
  10. ELINAV E, Nowarski R, Thaiss Ca, HU B, Jin C, Flavell ra. Inflammatory cancer: interaction between tumors, immune cells and microorganisms. NAT RER Cancer. 2013; 13 (11): 759-771.
  11. Wu N., Yang X., Zhang R. et al. Dysbiosis signature of the fecal microbiota in intestinal cancer patients. Microb Ecol. 2013; 66 (2): 462-470.
  12. Schwabe RF, Jobin C. The microbioma and cancer. NAT RE REM Cancer. 2013; 13 (11): 800-812.